Evidence map›Paper›PMID 38189812›Full record

SynthesisAging2024

The predictive value of sarcopenia and myosteatosis in trans-arterial (chemo)-embolization treated HCC patients.

Jing Long, Xin Zhang, Wei Mi, Jianjun Shi, Hongwei Ren, Qiang Wang

Open access · hybridAbstract readMeta-Analysis
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Aging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 3 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 3 syntheses or guidelines pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jing LongDepartment of Interventional Radiology, Tianyou Hospital Affiliated to Wuhan University of Science and Technology, Hubei, P.R. China.
Xin ZhangDepartment of Interventional Radiology, Tianyou Hospital Affiliated to Wuhan University of Science and Technology, Hubei, P.R. China.
Wei MiDepartment of Interventional Radiology, Tianyou Hospital Affiliated to Wuhan University of Science and Technology, Hubei, P.R. China.
Jianjun ShiDepartment of Interventional Radiology, Tianyou Hospital Affiliated to Wuhan University of Science and Technology, Hubei, P.R. China.
Hongwei RenDepartment of Imaging, Tianyou Hospital Affiliated to Wuhan University of Science and Technology, Hubei, P.R. China.
Qiang WangDepartment of Interventional Radiology, Tianyou Hospital Affiliated to Wuhan University of Science and Technology, Hubei, P.R. China.
Wuhan University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe conducted a meta-analysis to provide evidence-based results for the predictive values of sarcopenia, skeletal muscle index, psoas muscle index and the myosteatosis regarding the impact of survival outcomes and tumor response in patients treated by trans-arterial (chemo)-embolization (TAE/TACE), thereby optimizing therapeutic strategies and maximizing clinical benefits for hepatocellular carcinoma patients.

methodsQualified studies were retrieved from PubMed, the Cochrane Library, EMBASE, and Google Scholar before June 19, 2023. We investigated the relationships between sarcopenia, SMI, PMI, myosteatosis, and the overall survival of TAE/TACE-treated hepatocellular carcinoma patients with pooling data.

resultsA total of 167 studies were collected and 12 studies were finally included for analysis. The meta-analysis assisted that the sarcopenia (HR: 1.46, 95% CI: 1.30-1.64,

conclusionSarcopenia, skeletal muscle index and psoas muscle index, are significant prognostic predictors for TAE/TACE treated hepatocellular carcinoma patients. While myosteasis does not demonstrate a prognostic impact on the overall survival of TAE/TACE treated hepatocellular carcinoma patients.

Indexed as

Carcinoma, HepatocellularEmbolization, TherapeuticLiver NeoplasmsSarcopeniaHumansMuscle, SkeletalPrognosishepatocellular carcinomamyosteasisprognosispsoas muscle indexsarcopeniaskeletal muscle indextrans-arterial (chemo)-embolization

Identifiers

PMID38189812
PMCPMC10817392
OpenAlexW4390617652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.